Proscia: Record year comes as the rise of precision medicine drives a surge in demand Philadelphia – January 13, 2025 – Proscia®, a global leader in AI-enabled pathology solutions for precision medicine, more than doubled its growth in...

Proscia also ranks as the top vendor in diagnostic digital pathology market landscapes Philadelphia – December 5, 2024 – CB Insights named Proscia®, a global leader in AI-enabled pathology solutions for precision medicine, to...

Proscia: Recognized for product and customer traction in accelerating digital pathology market Philadelphia – December 3, 2024 – Proscia®, a global leader in AI-enabled pathology solutions for precision medicine, has been named...

Proscia: Rewiring cancer diagnosis through digitization and AI to improve patient outcomes Philadelphia – November 20, 2024 – Proscia®, a global leader in AI-enabled pathology solutions for precision medicine, was named to Fast...

Owkin’s MSIntuit® CRC v2*, a next-generation AI diagnostic aimed at transforming the detection and treatment of colorectal cancer, will be integrated into Proscia’s Concentriq® software platform, making it available as part of...

Proscia & Bioptimus: Explore how foundation models can transform novel AI development in pathology Unlocking the Promise of Foundation Models in Pathology for AI-Driven Drug Discovery & Development November 6, 11:00 AM — 12:00...